
doi: 10.5070/d39tb7p0fp
pmid: 22031641
Melkersson-Rosenthal Syndrome (MRS) is a rare syndrome that is characterized by a triad of facial paralysis, chronic edema of the lip, and a fissured tongue. Most commonly, one element of the triad precedes the development of the other symptoms. We present a case of cheilitis granulomatosa (CG) as a manifestation of incomplete MRS. As the etiology remains unknown, treatment of CG is challenging. Intralesional glucocorticoids remain the first-line treatment, but recurrences are common. We discuss alternative treatment strategies that include combination therapy with other anti-inflammatory agents and biologics, such as infliximab.
Adult, Melkersson-Rosenthal Syndrome, Tumor Necrosis Factor-alpha, Biopsy, Anti-Inflammatory Agents, Antibodies, Monoclonal, Lidocaine, Syndrome, Injections, Intralesional, Triamcinolone, Infliximab, Lip, Crohn Disease, Humans, Female
Adult, Melkersson-Rosenthal Syndrome, Tumor Necrosis Factor-alpha, Biopsy, Anti-Inflammatory Agents, Antibodies, Monoclonal, Lidocaine, Syndrome, Injections, Intralesional, Triamcinolone, Infliximab, Lip, Crohn Disease, Humans, Female
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 8 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
